Nephrotoxicity associated with the use of intravenous colistin

Scandinavian Journal of Infectious Diseases

Volumn 41, Issue 10, 2009, Pages 767-769

  Santamaría, Cecilia ^a   Mykietiuk, Analia ^a   Temporiti, Elena ^a   Stryjewski, Martin E ^a   Herrera, Fabian ^a   Bonvehi, Pablo ^a  

^a CEMIC   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

CEPHALOSPORIN; CIPROFLOXACIN; COLISTIMETHATE; COLISTIN; CREATININE; IMIPENEM; MEROPENEM; MINOCYCLINE; PIPERACILLIN PLUS TAZOBACTAM; SULTAMICILLIN;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTION; ADULT; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ARTICLE; CREATININE BLOOD LEVEL; DRUG USE; FEMALE; HOSPITAL INFECTION; HUMAN; KIDNEY FAILURE; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; MULTIDRUG RESISTANCE; NEPHROTOXICITY; RETROSPECTIVE STUDY; SEPTICEMIA; SURGICAL INFECTION; TREATMENT DURATION; URINARY TRACT INFECTION; VENTILATOR ASSOCIATED PNEUMONIA;

ACINETOBACTER INFECTIONS; ADULT; ANTI-BACTERIAL AGENTS; COLISTIN; CREATININE; HUMANS; INJECTIONS, INTRAVENOUS; KIDNEY DISEASES; KIDNEY FUNCTION TESTS; MICROBIAL SENSITIVITY TESTS; RETROSPECTIVE STUDIES; STATISTICS, NONPARAMETRIC;

EID: 72449186660     PISSN: 00365548     EISSN: 16511980     Source Type: Journal    
DOI: 10.1080/00365540903147001     Document Type: Article

References (6)

1. Ryan KJ, Schainuck LI, Hickman RO, Striker GE. Colistimethate toxicity: report of a fatal case in previously healthy child. JAMA 1969;/207:/2099-101.
2. Price DJ, Graham DI. Effects of large doses of colistin sulphomethate sodium on renal function. Br Med J 1970;/4:/ 525-527
3. Michalopoulos A, Tsiodras S, Rellos K, Mentzelopoulos S, Falagas ME. Colistin treatment in patients with ICUacquired infections caused by multiresistant Gram-negative bacteria: the renaissance of an old antibiotic. Clin Microbiol Infect 2005;/11:/115-21.
4. Markou N, Apostolakos H, Koumoudiou C, Athanasiou M, Koutsoukou A, Alamanos I, et al. Intravenous colistin in the treatment of sepsis from multiresistant Gram-negative bacilli in critically ill patients. Crit Care 2003;/7:/R78-83.
5. Falagas ME, Rizos M, Bliziotis IA, Rellos K, Kasiakou SK, Michalopoulos A. Toxicity after prolonged (more than four weeks) administration of intravenous colistin. BMC Infect Dis 2005;/5:/1.
6. Reina R, Estenssoro E, Saenz G, Canales HS, Gonzalvo R, Vidal G, et al. Safety and efficacy of colistin in Acinetobacter and Pseudomonas infections: a prospective cohort study. Int Care Med 2005;/31:/1058-65.